Hepatitis C News

Transplanting organs from donors with hepatitis C virus may increase the number of transplants performed and reduce waitlist times, but the optimal treatment strategy for recipients requires further investigation, according to a speaker.

In an exclusive video, Ray Chung, MD, detailed abstracts presented by the American Association for Study of Liver Diseases presented during Digestive Disease Week.

A collaborative approach between nephrologists and gastroenterologists led to improvements in the diagnosis and treatment of hepatitis C virus across 31 dialysis facilities in Changhua County, Taiwan.

Despite the SARS-CoV-2 pandemic, WHO has not yet changed their elimination targets for viral hepatitis, nor should they.

Prior to the COVID-19 pandemic, WHO set a target to eliminate viral hepatitis around the world by 2030. But, as focus necessarily turned toward the pandemic, the organization seems to now doubt viral hepatitis elimination goals will be met.

Outcomes have improved significantly among HIV/Hepatitis C virus-coinfected liver transplant recipients in the direct-acting antiviral era, according to data presented at the Digestive Disease Week.

More patients underwent hepatitis C virus screening when there was a reduced effort in attaining a laboratory order compared with patients who had to request screening on their own, according to research published in BMJ.

May is Hepatitis Awareness Month in the United States, and May 19 is Hepatitis Testing Day.

The COVID-19 pandemic caused major decreases in hepatitis C virus testing and treatment, hindering efforts to meet WHO goals for 2030, according to a study in the American Journal of Preventive Medicine.

Brii Biosciences, Vir Biotechnology and VBI Vaccines announced the first patient dosed in a phase 2 trial evaluating combination therapy for the treatment of patients with chronic hepatitis B infection, according to a press release.